Atlas Trials

Phase II Multicenter, Open-label, Single Arm Clinical Study of Pomalidomide and dexamethasonE and Cyclophosphamide

Clinical trial NCT02046915 · COMPLETED

Trial details

NCT number
NCT02046915
Sponsor
University Hospital Tuebingen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Multiple Myeloma
Start date
2014-04-01
Primary completion
2016-08-17
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.